Prepn: K. C. Murdock et al., DE 2850822; K. C. Murdock, F. E. Durr, US 4258181 (1979, 1981 both to Am. Cyanamid); and antitumor activity: K. C. Murdock et al., J. Med. Chem. 25, 505 (1982). Crystallographic characterization of hydrochloride: R. B. Bates et al., Acta Crystallogr. C42, 186 (1986); C. G. Pierpont, S. A. Lang, Jr., ibid. 1085. HPLC determn in plasma: Y.-M. Peng et al., J. Chromatogr. 233, 235 (1982). Antitumor activity in vitro: J. D. Cowan et al., Invest. New Drugs 1, 139 (1983); in vivo: R. V. Citarella et al., Cancer Res. 42, 440 (1982). Clinical pharmacokinetics: K. Lu et al., Cancer Chemother. Pharmacol. 16, 156 (1986). Clinical trials in breast cancer: H.-Y. Yap et al., Cancer Res. 43, 1402 (1983); C. K. Osborne et al., Cancer Treat. Rep. 68, 357 (1984).
Antineoplastic.
Antineoplastic